Sangamo Therapeutics Inc (SGMO) Stock: Is It Time for a Major Shift?
Truist has recently raised Sangamo Therapeutics Inc (SGMO) stock to Buy rating, as announced on December 13, 2024, according to Finviz. Earlier, on December 10, 2024, H.C. Wainwright had reiterated the stock to Buy, setting a price target of $10. RBC Capital Mkts also reduced Sector Perform rating with a price target of $2. Additionally, […]
Sangamo Therapeutics Inc (SGMO) Stock: Will It Continue to Defy the Market?
Truist has recently raised Sangamo Therapeutics Inc (SGMO) stock to Buy rating, as announced on December 13, 2024, according to Finviz. Earlier, on December 10, 2024, H.C. Wainwright had reiterated the stock to Buy, setting a price target of $10. RBC Capital Mkts also reduced Sector Perform rating with a price target of $2. Additionally, […]
Sangamo Therapeutics Inc (SGMO) Stock: Here’s Why It Might Be Time to Act Fast
Truist has recently raised Sangamo Therapeutics Inc (SGMO) stock to Buy rating, as announced on December 13, 2024, according to Finviz. Earlier, on December 10, 2024, H.C. Wainwright had reiterated the stock to Buy, setting a price target of $10. RBC Capital Mkts also reduced Sector Perform rating with a price target of $2. Additionally, […]
Sangamo Therapeutics Inc (SGMO) Stock: The Real Reason It’s Heading Higher
Truist has recently raised Sangamo Therapeutics Inc (SGMO) stock to Buy rating, as announced on December 13, 2024, according to Finviz. Earlier, on December 10, 2024, H.C. Wainwright had reiterated the stock to Buy, setting a price target of $10. RBC Capital Mkts also reduced Sector Perform rating with a price target of $2. Additionally, […]
Is Sangamo Therapeutics Inc (SGMO) Stock’s Growth Ready to Take Off Again?
Truist has recently raised Sangamo Therapeutics Inc (SGMO) stock to Buy rating, as announced on December 13, 2024, according to Finviz. Earlier, on December 10, 2024, H.C. Wainwright had reiterated the stock to Buy, setting a price target of $10. RBC Capital Mkts also reduced Sector Perform rating with a price target of $2. Additionally, […]
Is Sangamo Therapeutics Inc (SGMO) Stock’s Growth Ready to Drop Again?
Truist has recently raised Sangamo Therapeutics Inc (SGMO) stock to Buy rating, as announced on December 13, 2024, according to Finviz. Earlier, on December 10, 2024, H.C. Wainwright had reiterated the stock to Buy, setting a price target of $10. RBC Capital Mkts also reduced Sector Perform rating with a price target of $2. Additionally, […]
Sangamo Therapeutics Inc (SGMO) Stock: Are You Ready for the Upcoming Drop?
Truist has recently raised Sangamo Therapeutics Inc (SGMO) stock to Buy rating, as announced on December 13, 2024, according to Finviz. Earlier, on December 10, 2024, H.C. Wainwright had reiterated the stock to Buy, setting a price target of $10. RBC Capital Mkts also reduced Sector Perform rating with a price target of $2. Additionally, […]
Is Sangamo Therapeutics Inc (SGMO) Stock About to Explode? Here’s What You Need to Know
Truist has recently raised Sangamo Therapeutics Inc (SGMO) stock to Buy rating, as announced on December 13, 2024, according to Finviz. Earlier, on December 10, 2024, H.C. Wainwright had reiterated the stock to Buy, setting a price target of $10. RBC Capital Mkts also reduced Sector Perform rating with a price target of $2. Additionally, […]
The Shocking Truth Behind I-80 Gold Corp (IAUX) Stock’s Recent Decline
Truist has recently raised Sangamo Therapeutics Inc (SGMO) stock to Buy rating, as announced on December 13, 2024, according to Finviz. Earlier, on December 10, 2024, H.C. Wainwright had reiterated the stock to Buy, setting a price target of $10. RBC Capital Mkts also reduced Sector Perform rating with a price target of $2. Additionally, […]
Sangamo Therapeutics Inc (SGMO) Stock: A Hidden Gem or Just a Bubble Waiting to Burst?
Truist has recently raised Sangamo Therapeutics Inc (SGMO) stock to Buy rating, as announced on December 13, 2024, according to Finviz. Earlier, on December 10, 2024, H.C. Wainwright had reiterated the stock to Buy, setting a price target of $10. RBC Capital Mkts also reduced Sector Perform rating with a price target of $2. Additionally, […]
